Because of the potential link between GLP-1 drugs and thyroid cancer, those with MEN 2 should avoid these medications
North America leads the GLP-1 autoinjector and pen injector market primarily due to the high prevalence of Type 2 Diabetes and Obesity, which has significantly increased the demand for GLP-1 therapies and their delivery devices
Moving from Tirzepatide to Semaglutide If you are switching from tirzepatide to semaglutide, your healthcare provider will likely have you start at a lower dose of semaglutide, usually 0.25 mg or 0.5 mg weekly
For people who discover an unexpected pregnancy while on tirzepatide, the situation detailed in our guide on pregnancy on tirzepatide provides the specific guidance needed
As more people use semaglutide for diabetes or weight loss, these questions are becoming more common
Everyones needs differ, and calorie and protein targets vary based on your body, activity level, and medication